Prescription Required.Why?
An alpha2-adrenergic agonist, primarily used for its effects on reducing intraocular pressure.
A viscosity-increasing agent used to improve the formulation's retention time and spreadability in the eye.
Treatment of openangle glaucoma.
Treatment of ocular hypertension.
Brimonidine tartrate reduces intraocular pressure (IOP) by decreasing aqueous humor production and increasing uveoscleral outflow. Polyvinyl Alcohol serves as a vehicle to enhance drug delivery and prolong its effect.
Store at room temperature (20-25°C), protect from light and moisture. Discard any unused solution after the expiry date.
Instill one or two drops in the affected eye(s) as directed by your ophthalmologist.
The frequency of administration depends on your individual needs and should be determined by your doctor.
Do not touch the dropper tip to any surface to avoid contamination.
Eye irritation (burning, stinging, itching)
Dry eyes
Blurred vision
Headache
Dry mouth
Fatigue
Allergic reactions (rare)
The interaction between alcohol and brimonidine tartrate is not well-documented. Consult your doctor or pharmacist if you have concerns about alcohol consumption while using this medication.
Brimonidine tartrate may cause blurred vision. Avoid driving or operating machinery until your vision is clear.
Consult your doctor before using brimonidine tartrate if you are pregnant, planning to become pregnant, or breastfeeding. The safety of brimonidine tartrate during pregnancy and breastfeeding has not been fully established.
Safety and efficacy in children have not been fully established. Use only as prescribed by an ophthalmologist.
Caution should be exercised in patients with severe kidney impairment. Your doctor may need to adjust the dosage.
Caution should be exercised in patients with severe liver impairment. Your doctor may need to adjust the dosage.
Your ophthalmologist
The medication package insert
Reputable medical websites such as the FDA or NIH.
